University of Utah

Company

Related News

AI Tools Accelerate Cancer Drug Testing and Clinical Trial Enrollment

New AI-powered platforms enable same-day cancer treatment decisions and streamline clinical trial matching. University of Utah's μPharma chip predicts drug responses in under four hours, while City of Hope's HopeLLM system matches patients to trials across its national network.

Related Clinical Trials

NCT ID Title Status Phase
NCT07599943

Population Health Management -Increase Lung Cancer Screening in Community Health Centers (LungSMART)

NOT_YET_RECRUITING NA
NCT07586917

Optimizing Pregnancy and Treatment Interventions for Moms 3.0

NOT_YET_RECRUITING NA
NCT07582211

Bilevel Positive Airway Pressure (BPAP) for Severe Asthma

NOT_YET_RECRUITING NA
NCT07582042

Lesion-tailored, Fundus-controlled Perimetry in Geographic Atrophy (GA).

NOT_YET_RECRUITING
NCT07582016

Partnership to Reduce Obesity in Community Health Center Patients (SMARTLife Utah)

NOT_YET_RECRUITING NA
NCT07577765

Testing a Tailored Approach to Long-Term Weight Loss Success

RECRUITING NA
NCT07573436

Loncastuximab Tesirine and Rituximab as First-line Therapy in Patients With Post-transplant Lymphoproliferative Disorder (PLUTO)

NOT_YET_RECRUITING PHASE1/PHASE2
NCT07570056

Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)

NOT_YET_RECRUITING
NCT07565883

Adolescent Probiotics in Stressed Adolescents

COMPLETED NA
NCT07563296

KALM-B: Ketamine-assisted Psychotherapy (KAP) to Lessen Morbidity After Burn Injury

NOT_YET_RECRUITING PHASE2